Hyalex 首次人体研究
HYALEX® 软骨系统的前瞻性、多中心、单臂、两阶段首次人体可行性研究
The Hyalex First-in-Human Study is a prospective, multicenter, open-label, single-arm, 2-phase, first-in-human study to evaluate the safety and technical performance of the HYALEX Knee Cartilage System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Lodz、波兰、09-038
- SPORTO
-
Warsaw、波兰、00-855
- LIFE Medical Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria - Phase 1
- 21-65 years.
- Body Mass Index (BMI) ≤ 35.
- Singular treatable joint surface lesion, ICRS Grade 3 or 4, located on the medial or lateral femoral condyle.
- Symptomatic, single treatable area 1 - 3.8cm2.
- Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale score between 20 and 65.
- Stable knee.
- Non-responsive to a minimum of 3 weeks of conservative treatment, consisting of non-steroidal anti-inflammatory drugs and/or physical therapy.
Inclusion Criteria - Phase 2
- 21-65 years.
- Body Mass Index (BMI) ≤ 35.
- Up to three treatable joint surface lesion(s), ICRS Grade 3 or 4, located on the medial or lateral femoral condyle(s).
- Symptomatic total treatable area 1 - 10cm2.
- Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale score between 20 and 65.
- Stable knee.
- Non-responsive to a minimum of 3 weeks of conservative treatment, consisting of non-steroidal anti-inflammatory drugs and/or physical therapy.
Exclusion Criteria - Phase 1 & 2
HYALEX Implant, Surgical Technique, and Lesion Site Exclusions:
- Known allergy to polyurethanes, bone cement, acrylic, or titanium.
- Lack of 2mm of healthy cartilage (ICRS Grade 0 or 1) and 2mm of vital bone wall on all sides of the implant site.
- Osteochondral defect affecting subchondral bone more than 11mm in depth from adjacent non-defect articular surface.
- Bipolar cartilage lesions involving patellar or tibial lesions ICRS Grade 3 - 4 opposite the lesion intended for treatment.
- Insufficient bone stock or bone density determined intra-operatively preventing implant press fit.
Patient Orthopaedic Health Exclusions:
- Kellgren and Lawrence (KL) grade 3 or 4 on standing radiographs as defined:
- Hip-knee-ankle (HKA) angle of greater than +/- 5 degrees (varus or valgus malalignment > 5 degrees) on standing X-ray.
- Lack of normally functioning contralateral knee that restricts activity.
- Insufficiency fracture of the femoral condyle or tibial plateau.
- Recent Osteochondritis Dissecans within 1 year.
- Diagnosis of a concomitant knee injury which the investigator believes may interfere with study participation or confound effectiveness assessment.
- Any known systemic cartilage and/or bone disorder, such as but not limited to osteoporosis, chondrodysplasia or osteogenesis imperfecta.
- A symptomatic musculoskeletal condition in the lower limbs that could impede effectiveness measurements in the target knee.
- Any known tumor of the treatment knee.
- Prior radiation therapy to the knee joint.
- Clinically significant or symptomatic vascular or neurological disorder of the lower extremities affecting gait or function.
- Untreated ACL and/or PCL deficiency or complex ligamentous instability of the study knee according to IKDC Grade C (abnormal) or D (severely abnormal).
Previous Surgery and Intervention Exclusions:
-
Previous surgery in the past 6 months on the index knee except for:
- Diagnostic knee arthroscopy and/or debridement / chondroplasty, and
- Meniscectomy
-
Previous intra-articular injections, including HA and steroids, within the last 3 months prior to the date of surgery.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Hyalex Cartilage System
Implantation of Hyalex Cartilage Knee Implant |
Implantation of Hyalex Cartilage Knee Implant. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Freedom from implant rejection and infection.
大体时间:Through 24 months.
|
Assess the safety (implant rejection, infection) and tolerability of the Hyalex Cartilage Implant. |
Through 24 months.
|
|
Change in the Knee Injury & Osteoarthritis Outcome Score (KOOS) from baseline at 12 months.
大体时间:Through 12 months.
|
The KOOS assesses patient pain, other symptoms, function in daily living, function in sport and recreation, and knee related quality of life. Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. |
Through 12 months.
|
合作者和调查者
调查人员
- 首席研究员:Marcin Domzalski, MD、SPORTO, Łódź, Poland
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.